Back
PharmaCyte Biotech, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
PMCB
PharmaCyte Biotech, Inc.
Last Price:
$0.88
Seasonality Move:
35.79%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PMCB is experiencing slight buying pressure.
PharmaCyte Biotech, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.94 | Sell |
| 20-day SMA: | 0.91 | Sell |
| 50-day SMA: | 0.91 | Sell |
| 200-day SMA: | 1.06 | Sell |
| 8-day EMA: | 0.45 | Buy |
| 20-day EMA: | 0.22 | Buy |
| 50-day EMA: | 0.1 | Buy |
| 200-day EMA: | 0.02 | Buy |
PharmaCyte Biotech, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 45.87 | Sell |
| Chaikin Money Flow: | -28580 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 1.04) | Sell |
| Bollinger Bands (100): | (0.83 - 1.05) | Sell |
PharmaCyte Biotech, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for PharmaCyte Biotech, Inc. Stock
Is PharmaCyte Biotech, Inc. Stock a Buy?
-
PharmaCyte Biotech, Inc. share price is 0.86 while PMCB 8-day simple moving average is 0.94, which is a Sell signal.
-
The stock price of PMCB is 0.86 while PharmaCyte Biotech, Inc. 20-day SMA is 0.91, which makes it a Sell.
-
PharmaCyte Biotech, Inc. 50-day simple moving average is 0.91 while PMCB share price is 0.86, making it a Sell technically.
-
PMCB stock price is 0.86 and PharmaCyte Biotech, Inc. 200-day simple moving average is 1.06, creating a Sell signal.
PMCB Technical Analysis vs Fundamental Analysis
Sell
41
PharmaCyte Biotech, Inc. (PMCB)
is a Sell
Is PharmaCyte Biotech, Inc. a Buy or a Sell?
-
PharmaCyte Biotech, Inc. stock is rated a SellThe current PharmaCyte Biotech, Inc. [PMCB] share price is $0.86. The Score for PMCB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
PharmaCyte Biotech, Inc. Stock Info
Market Cap:
8.7M
Price in USD:
0.86
Share Volume:
212K
PharmaCyte Biotech, Inc. 52-Week Range
52-Week High:
1.90
52-Week Low:
0.63
Sell
41
PharmaCyte Biotech, Inc. (PMCB)
is a Sell
PharmaCyte Biotech, Inc. Share Price Forecast
-
What is the PharmaCyte Biotech, Inc. stock price today?The PharmaCyte Biotech, Inc. stock price is 0.86 USD today.
-
Will PMCB stock go up or go down?PharmaCyte Biotech, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is PharmaCyte Biotech, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, PharmaCyte Biotech, Inc. is overvalued.
Is PharmaCyte Biotech, Inc. Stock a Buy?
-
PharmaCyte Biotech, Inc. share price is 0.86 while PMCB 8-day exponential moving average is 0.45, which is a Buy signal.
-
The stock price of PMCB is 0.86 while PharmaCyte Biotech, Inc. 20-day EMA is 0.22, which makes it a Buy.
-
PharmaCyte Biotech, Inc. 50-day exponential moving average is 0.10 while PMCB share price is 0.86, making it a Buy technically.
-
PMCB stock price is 0.86 and PharmaCyte Biotech, Inc. 200-day simple moving average is 0.02, creating a Buy signal.
Technical Analysis of PharmaCyte Biotech, Inc.
Should I short PharmaCyte Biotech, Inc. stock?
-
PMCB Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting PharmaCyte Biotech, Inc. is a Buy
-
PharmaCyte Biotech, Inc. Relative Strength Index (RSI) is 45.87, which suggest PharmaCyte Biotech, Inc. is oversold
-
The Bollinger Bands (25) for PharmaCyte Biotech, Inc. is (0.7 - 1.04), which suggest PharmaCyte Biotech, Inc. is a Sell
-
The Bollinger Bands (100) for PharmaCyte Biotech, Inc. is (0.83 - 1.05), which suggest PharmaCyte Biotech, Inc. is a Sell
* PharmaCyte Biotech, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.